Beryl Drugs Ltd
Beryl Drugs Ltd Live Price Chart
Performance
| Previous Close | ₹ 24.54 |
| High | ₹ 26.95 |
| Volume | 3498 |
| 52W Range | ₹ 15.92 - ₹ 27.6 |
| Open | ₹ 25.5 |
| Low | ₹ 24.4 |
| Market Cap | ₹ 12.96 Cr |
Beryl Drugs Ltd Technicals
| 20 Day | ₹ 24.456 |
| 50 Day | ₹ 23.737 |
| 100 Day | ₹ 23.117 |
| 200 Day | ₹ 23.028 |
| 20 Day | ₹ 24.321 |
| 50 Day | ₹ 23.517 |
| 100 Day | ₹ 22.742 |
| 200 Day | ₹ 22.301 |
Beryl Drugs Ltd Fundamentals
| ROCE | 7.563 |
| P/E Ratio | 21.390 |
| P/B Ratio | 1.350 |
| Industry P/E | 1.350 |
| Debt to Equity | 49.246 |
| ROE | 4.296 |
| EPS | 1.230 |
| Dividend Yield | 0.000 |
| Book Value | 19.452 |
| Face Value | 10.000 |
Beryl Drugs Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 19.3102 | 22.5548 | 27.1247 | 27.1565 | 14.7686 |
| Total Expenses | 18.7222 | 21.6891 | 26.115 | 26.1726 | 15.7189 |
| Profit After Tax | 0.4248 | 0.5788 | 0.7686 | 0.766 | -0.659 |
Beryl Drugs Ltd Shareholding Pattern
| Promoter Holdings | 27.816 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 63.560 % |
| Others - | 8.624 % |
About Beryl Drugs Ltd
Beryl Drugs Limited was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V. fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India. Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERI-CEF injection, F-Neuron, Amplocillin INJ, P-Mol, Biprox, B-Flox and many more. The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products. ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 40.31 -0.92 (-2.23%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 508.00 +3.75 (+0.74%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 5,850.00 +145.95 (+2.56%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 658.70 -12.6 (-1.88%) |
| Abbott India Ltd Pharmaceuticals | ₹ 25,980.00 +350.2 (+1.37%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,303.30 -1.7 (-0.13%) |
FAQs on Beryl Drugs Ltd
1. Can I buy Beryl Drugs Ltd from PL Capital? ›
2. Does Beryl Drugs Ltd pay dividends? ›
3. What is the current share price of Beryl Drugs Ltd ? ›
4. What is the 52-week high and low of Beryl Drugs Ltd ? ›
5. What is the market capitalisation of Beryl Drugs Ltd? ›
6. What is the current P/E ratio of Beryl Drugs Ltd? ›
7. What is the current P/B ratio of Beryl Drugs Ltd? ›
8. What is the shareholding pattern of Beryl Drugs Ltd? ›
9. What is the 1-year return of Beryl Drugs Ltd? ›
Start SIP in Beryl Drugs Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
